General
Preferred name
ZICONOTIDE
Synonyms
SNX-111 ()
.omega.-conotoxin m viia ()
Ziconotida ()
Ziconotide (trifluoroacetate salt) ()
P&D ID
PD046816
CAS
107452-89-1
1660960-77-9
Tags
available
drug
Approved by
FDA
First approval
2004
Drug indication
Pain
Traumatic brain injury
Drug Status
approved
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Ziconotide is the INN for synthetically produced ω-conotoxin which was identified and extracted from the venom of Conus magus (Magus cone or Magician's cone snail).
(GtoPdb)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
8
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Guide to Pharmacology
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
31
Molecular Weight
2637.1
Hydrogen Bond Acceptors
45
Hydrogen Bond Donors
42
Rotatable Bonds
38
Ring Count
4
Aromatic Ring Count
1
cLogP
-16.21
TPSA
1133.84
Fraction CSP3
0.67
Chiral centers
22.0
Largest ring
43.0
QED
0.01
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Therapeutic Class
Analgesics
Source data

